Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GLEYBIS SANCHEZ

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1952682973
CMS profile
874253
Location
ROCKINGHAM, NC

General Payments · PY2018–2024

$5,146.07

  • Reported across 338 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$551.26

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $551.26 39

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,053.29 74
PY2019 $1,104.29 82
PY2020 $573.09 35
PY2021 $372.20 22
PY2022 $761.38 37
PY2023 $730.56 49
PY2024 $551.26 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.68 06/21/2024 Food and Beverage Undisputed 01/23/2026 1106012251 CMS
AstraZeneca Pharmaceuticals LP $17.76 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104502490 CMS
AstraZeneca Pharmaceuticals LP $14.59 04/18/2024 Food and Beverage Undisputed 01/23/2026 1104782720 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.81 04/17/2024 Food and Beverage Undisputed 01/23/2026 1118249767 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.90 07/31/2024 Food and Beverage Undisputed 01/23/2026 1118249769 CMS
Exact Sciences Corporation $16.30 03/06/2024 Food and Beverage Undisputed 01/23/2026 1114872071 CMS
Exact Sciences Corporation $21.50 06/13/2024 Food and Beverage Undisputed 01/23/2026 1114872076 CMS
GlaxoSmithKline, LLC. $19.48 01/17/2024 Food and Beverage Undisputed 01/23/2026 1116325494 CMS
GlaxoSmithKline, LLC. $11.80 02/21/2024 Food and Beverage Undisputed 01/23/2026 1116331304 CMS
GlaxoSmithKline, LLC. $17.38 03/13/2024 Food and Beverage Undisputed 01/23/2026 1116186077 CMS
GlaxoSmithKline, LLC. $14.67 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116588901 CMS
GlaxoSmithKline, LLC. $18.49 06/12/2024 Food and Beverage Undisputed 01/23/2026 1116444990 CMS
GlaxoSmithKline, LLC. $9.93 07/03/2024 Food and Beverage Undisputed 01/23/2026 1116057788 CMS
GlaxoSmithKline, LLC. $15.70 08/21/2024 Food and Beverage Undisputed 01/23/2026 1116685375 CMS
GlaxoSmithKline, LLC. $6.80 09/25/2024 Food and Beverage Undisputed 01/23/2026 1116058008 CMS
GlaxoSmithKline, LLC. $17.66 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116269893 CMS
Lilly USA, LLC $26.75 03/18/2024 Food and Beverage Undisputed 01/23/2026 1134989776 CMS
Lilly USA, LLC $17.02 06/06/2024 Food and Beverage Undisputed 01/23/2026 1134988268 CMS
Lilly USA, LLC $17.23 08/14/2024 Food and Beverage Undisputed 01/23/2026 1134988604 CMS
Lilly USA, LLC $14.27 09/11/2024 Food and Beverage Undisputed 01/23/2026 1134988606 CMS
Mylan Specialty L.P. $23.43 02/14/2024 Food and Beverage Undisputed 01/23/2026 1147326855 CMS
Mylan Specialty L.P. $23.28 05/01/2024 Food and Beverage Undisputed 01/23/2026 1147379167 CMS
Novartis Pharmaceuticals Corporation $16.29 07/17/2024 Food and Beverage Undisputed 01/23/2026 1087166043 CMS
Novo Nordisk Inc $7.45 01/25/2024 Food and Beverage Undisputed 01/23/2026 1097801999 CMS
Novo Nordisk Inc $12.19 02/15/2024 Food and Beverage Undisputed 01/23/2026 1096955251 CMS
Novo Nordisk Inc $5.73 03/18/2024 Food and Beverage Undisputed 01/23/2026 1097353269 CMS
Novo Nordisk Inc $10.75 03/27/2024 Food and Beverage Undisputed 01/23/2026 1097558211 CMS
Novo Nordisk Inc $15.80 04/25/2024 Food and Beverage Undisputed 01/23/2026 1097760275 CMS
Novo Nordisk Inc $7.43 05/21/2024 Food and Beverage Undisputed 01/23/2026 1097537959 CMS
Novo Nordisk Inc $5.77 06/18/2024 Food and Beverage Undisputed 01/23/2026 1096793081 CMS
Novo Nordisk Inc $14.56 06/27/2024 Food and Beverage Undisputed 01/23/2026 1096576661 CMS
Novo Nordisk Inc $9.55 08/15/2024 Food and Beverage Undisputed 01/23/2026 1097535530 CMS
Novo Nordisk Inc $12.20 09/05/2024 Food and Beverage Undisputed 01/23/2026 1097099283 CMS
Novo Nordisk Inc $8.49 09/06/2024 Food and Beverage Undisputed 01/23/2026 1096894915 CMS
Novo Nordisk Inc $12.80 10/09/2024 Food and Beverage Undisputed 01/23/2026 1096902205 CMS
Novo Nordisk Inc $3.21 10/24/2024 Food and Beverage Undisputed 01/23/2026 1097021776 CMS
Novo Nordisk Inc $5.76 11/19/2024 Food and Beverage Undisputed 01/23/2026 1097009457 CMS
Novo Nordisk Inc $17.47 12/04/2024 Food and Beverage Undisputed 01/23/2026 1097336099 CMS
Phathom Pharmaceuticals, Inc. $16.38 11/20/2024 Food and Beverage Undisputed 01/23/2026 1151120130 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.